CAN-FITE BIOPHARMA LTD's ticker is CANF and the CUSIP is 13471N102. A total of 5 filers reported holding CAN-FITE BIOPHARMA LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $100,000 | -13.0% | 41,837 | -4.6% | 0.01% | -27.3% |
Q3 2016 | $115,000 | -0.9% | 43,832 | -3.6% | 0.01% | -31.2% |
Q2 2016 | $116,000 | +9.4% | 45,489 | +19.4% | 0.02% | +14.3% |
Q1 2016 | $106,000 | -6.2% | 38,100 | -1.8% | 0.01% | 0.0% |
Q4 2015 | $113,000 | +121.6% | 38,800 | +218.0% | 0.01% | +75.0% |
Q3 2015 | $51,000 | +88.9% | 12,200 | 0.0% | 0.01% | +100.0% |
Q2 2015 | $27,000 | 0.0% | 12,200 | 0.0% | 0.00% | +33.3% |
Q1 2015 | $27,000 | – | 12,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TAYLOR ASSET MANAGEMENT INC | 796,500 | $1,346,000 | 0.43% |
Virtu Financial LLC | 11,169 | $19,000 | 0.00% |
Psagot Value Holdings Ltd. | 13,891 | $23,000 | 0.00% |
Citadel Advisors | 11,657 | $20,000 | 0.00% |
MORGAN STANLEY | 41,600 | $70,000 | 0.00% |
RAYMOND JAMES & ASSOCIATES | 12,200 | $21,000 | 0.00% |
UBS Group AG | 1,314 | $2,000 | 0.00% |
PRELUDE CAPITAL MANAGEMENT, LLC | 1,200 | $2,000 | 0.00% |